Jennifer Ma

Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma

Ghassan K. Abou‐Alfa, Shukui Qin, Baek‐Yeol Ryoo et al. · Annals of Oncology · 2018 · 255 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

<i>ERCC2</i> Helicase Domain Mutations Confer Nucleotide Excision Repair Deficiency and Drive Cisplatin Sensitivity in Muscle-Invasive Bladder Cancer

Qiang Li, Alexis Damish, Zoë Frazier et al. · Clinical Cancer Research · 2018 · 162 citations · Full text

Medicine, Molecular Biology, Oncology +15

A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas

J K Lee, Marinela Capanu, Eileen M. O’Reilly et al. · British Journal of Cancer · 2013 · 108 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium.

Celina Ang, Robin Katie Kelley, Michael A. Choti et al. · PubMed · 2013 · 104 citations

Medicine, Oncology, Surgery +15

A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma

Ghassan K. Abou‐Alfa, Marinela Capanu, Eileen M. O’Reilly et al. · Journal of Hepatology · 2013 · 97 citations · Full text

Medicine, Oncology, Pharmacology +14